Brazilian Registry of Chronic Diseases in People Living with HIV/AIDS

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

BRAVO is a multicenter, cross-sectional registry enrolling adults with HIV/AIDS across Brazil. The study collects sociodemographic data, risk factors, clinical tests, and biological samples to describe cardiometabolic health, mental health, and quality of life. Data are gathered through REDCap and include lipid and glucose panels, anthropometrics, organ function assessments, viral load, CD4/CD8 counts, ART adherence, and WHOQOL-BREF quality of life measures. The registry aims to estimate the prevalence of depression and other noncommunicable conditions to inform policy and care delivery for PLWHA. Participation is voluntary and requires informed consent at diverse clinical sites representing five geographic regions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 or over;
* Confirmed HIV or AIDS diagnosis;
* Signature of consent form.

Exclusion Criteria:

* Indigenous population or those in prison in open or closed regimes;
* Patients hospitalized at the time of signing the Consent Form.

Where it's running

• Hospital das Clínicas da Universidade Federal de Goiás
  Goiânia, Goiás, Brazil Recruiting
• Hospital de Clínicas da Universidade Federal do Paraná
  Curitiba, Paraná, Brazil Recruiting
• Hospital Federal dos Servidores do Estado do Rio de Janeiro
  Rio de Janeiro, Rio de Janeiro, Brazil Recruiting
• Hospital Federal de Santa Maria
  Santa Maria, Rio Grande do Sul, Brazil Recruiting
• Centro de Pesquisa Clínica Dom Bosco
  Araçatuba, São Paulo, Brazil Recruiting
• Centro Universitário FMABC
  Santo André, São Paulo, Brazil Recruiting

Study contacts

• Principal investigator: Victor Sato — Hospital Alemão Oswaldo Cruz
• Study coordinator: Victor Sato
• Email: victorhsato@gmail.com
• Phone: 5511

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Observational look at how Kremezin works in adults with advanced chronic kidney disease

  This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.

  Recruiting HK inno.N Corporation · Seoul · NCT07930169

• Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China

  This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.

  Recruiting Phase 4 Novo Nordisk A/S · Fuyang, Anhui and 25 other locations · NCT07900438

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• Arterial stiffness in children and young people with CKD and hypertension

  This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.

  Recruiting King's College London · London, Greater London · NCT07768865

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.